| Pharmaceutical active ingredients: |
| PyrimethamineSulfametopyrazine |
| Available forms, composition and doses of Metakelfin: |
| Tablets; Oral; Pyrimethamine 25 mg; Sulfametopyrazine 500 mg |
| Metakelfin medical category: |
| Human:Antimalarials |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J01ED02 - SulfaleneP01BD51 - Pyrimethamine, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pfizer |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Suldox | Pyrimethamine; Sulfadoxine | Actavis |
| Vivaxine | Pyrimethamine; Sulfadoxine | Nakorn; TNP Health Care; V & V Bangkok |
| Malarwin | Pyrimethamine; Sulfamethoxazole | Wings Pharmaceuticals |
| Pyramet | Pyrimethamine; Sulfamethoxazole | Cipla |
| Dafrafin | Pyrimethamine; Sulfametopyrazine | Dafra Pharma |
| Periodine Anti-Malarico | Pyrimethamine; Sulfametopyrazine | Simoes Laboratorio |
| Quinnoxine-S | Pyrimethamine; Sulfaquinoxaline | Vetoquinol |
| Sulfaquinoxaline-S | Pyrimethamine; Sulfaquinoxaline | Medprodex |
| Prac-Tic | Pyriprole | Novartis |
| Dan-Tar Plus | Pyrithione Disulfide; Tar | Valeo Pharma; Stiefel Laboratories |